X
May 24, 2022 05:20 PM (GMT+8) · EqualOcean
Hengrui pharmaceutical announced that recently, Shanghai Hengrui Pharmaceutical Co., Ltd., a subsidiary of the company, received the notice of approval of drug clinical trial on hr19024 injection approved and issued by the State Food and Drug Administration and agreed to carry out the clinical trial of advanced solid tumor.